Octaplex® is a prothrombin complex concentrate (PCC) containing therapeutic and balanced levels of Factors II, VII, IX and X, as well as inhibitory proteins C and S. Octaplex® has been shown to provide rapid INR reversal within 10 minutes1, with a small volume (500 IU in 20 mL per vial) and short infusion time2.
Fibryga® is indicated for treatment of bleeding and perioperative prophylaxis in patients with congenital hypo or afibrinogenaemia with bleeding tendency. It can also be used as a complementary therapy to manage uncontrolled severe haemorrhage in patients with acquired hypofibrinogenaemia during surgical intervention.
Octagam® is a human normal immunoglobulin (IVIg) that is indicated for replacement therapy in patients with primary immunodeficiency syndromes, myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections, and children with congenital AIDS and recurrent infections. It is also used in immunomodulation of idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, in patients with Guillain Barré syndrome and Kawasaki disease.